Foghorn Therapeutics Inc
(NAS:FHTX)
$
6.67
-0.15 (-2.19%)
Market Cap: 396.40 Mil
Enterprise Value: 272.81 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 67/100 Foghorn Therapeutics Inc. at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023 / 06:15PM GMT
Release Date Price:
$7.57
(+2.99%)
Vikram Purohit
Morgan Stanley & Co LLC - Analyst
All right, welcome, everyone. Thanks for joining. My name is Vikram Purohit, I'm one of the biotech analysts with the research team. This is the fireside chat with Foghorn Therapeutics.
Before we kick it off, I just need to read a brief disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
With that, I'm very happy to have with me the CEO of Foghorn, Adrian Gottschalk. I said that correctly?
Adrian Gottschalk
Foghorn Therapeutics Inc - President & CEO
You get it right every year.
Vikram Purohit;Adrian Gottschalk
Morgan Stanley & Co LLC - Analyst;Foghorn Therapeutics Inc - President
Okay. Thanks for joining us. Appreciate it.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot